Gilead Sciences (GILD) Asset Utilization Ratio (2009 - 2026)

Gilead Sciences (GILD) reported Asset Utilization Ratio of 0.52 for Q1 2026, up 3.6% on a YoY basis from 0.5 in Q1 2025, and up 2.97% quarter-over-quarter from 0.5 in Q4 2025.

Gilead Sciences (GILD) Asset Utilization Ratio (2009 - 2026) Analysis & Trends

Gilead Sciences has reported Asset Utilization Ratio for 18 years, with the latest figure at 0.52 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 3.6% year-over-year to 0.52; the trailing twelve-month figure through Mar 2026 stood at 0.52 (up 3.6% YoY), and the FY2025 full-year result was 0.5, up 5.09% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.52, up from 0.5 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.52 in Q3 2024, with the low at 0.42 in Q1 2022.
  • Historically, Asset Utilization Ratio has averaged 0.47 across 5 years, with a median of 0.46 in 2024.
  • Annual changes were most pronounced in 2024 — Asset Utilization Ratio increased 19.19% — and 2025, when it slipped 2.75%.
  • Gilead Sciences' Asset Utilization Ratio stood at 0.43 in 2022, then increased by 0.38% to 0.44 in 2023, then increased by 16.3% to 0.51 in 2024, then slipped by 1.12% to 0.5 in 2025, then gained by 2.97% to 0.52 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.52 (Q1 2026), 0.5 (Q4 2025), and 0.51 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 0.53
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 0.63
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 0.48
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 0.46
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 0.50
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 0.41
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 0.52
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 0.12
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 0.55
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.52
Dec 31, 2025 0.50
Sep 30, 2025 0.51
Jun 30, 2025 0.51
Mar 31, 2025 0.50
Dec 31, 2024 0.51
Sep 30, 2024 0.52
Jun 30, 2024 0.51
Mar 31, 2024 0.46
Dec 31, 2023 0.44
Sep 30, 2023 0.44
Jun 30, 2023 0.44
Mar 31, 2023 0.43
Dec 31, 2022 0.43
Sep 30, 2022 0.43
Jun 30, 2022 0.44
Mar 31, 2022 0.42
Dec 31, 2021 0.40
Sep 30, 2021 0.41
Jun 30, 2021 0.39